Author's posts
At Joe Biden’s Urging, Airbnb, WeWork, And Others Commit To Help Cancer Patients
The companies are committing to find ways to use their businesses to help patients with cancer.
Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board
uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person’s stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug developme…
For A New Device To Treat Maternal Bleeding, A Young Entrepreneur’s Big Step Was Passing The Torch
This morning, Alydia Health, a tiny Menlo Park, Calif., startup co-founded by a 21-year-old woman, announced that it has secured $10 million in funding to test a medical device to prevent mothers from bleeding to death after childbirth.
A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids’ Deadly Diseases
“John, I’m very aware of your family’s journey, Twelve years ago I was one of the producers considering bidding on your life rights.”
If It Wanted To, The FDA Could Destroy E-Cigarette Makers
Past experience says that when the FDA has the will to use its regulatory power, it can shake whole industries. Companies like Juul should tread extremely carefully.
Semiautomatic Rifles May Make Mass Shootings Deadlier, Study Says
Mass shooters appear to injure and kill more people when the use semiautomatic rifles instead of handguns, other types of rifles, or shotguns, according to a new analysis in the Journal of The American Medical Association. But the research has signific…
How To Really Take Medical Conflicts Of Interest Seriously
If we’re going to have a central database of conflict of interest disclosures in medicine – and there is one, created by law – it’s high time that people start using it.
Pharma Billionaire Charged With Penny Stock Fraud
Miami’s Phillip Frost, who built a $2.8 billion fortune in the generic drug business, was allegedly involved in a tawdry stock promotion scheme, the Securities and Exchange Commission says.
Of Vampires And The Challenges Of Longevity Drugs
For an example of how hard it is to develop an anti-aging medicine, check this out. It’s some of the coolest and creepiest science to have been published in major academic journals. But is it ready to form the basis of a pharmaceutical company?
Jackie Fouse, Admired By Investors, To Become CEO Of Biotech Agios
“It’s a fabulous company and it’s at a perfect stage of its life cycle,” Fouse says. She notes that Agios has spent a decade proving itself, and now has two approved products.
